220 related articles for article (PubMed ID: 15315862)
41. Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.
Ekman A; Hokynar K; Kakkola L; Kantola K; Hedman L; Bondén H; Gessner M; Aberham C; Norja P; Miettinen S; Hedman K; Söderlund-Venermo M
J Virol; 2007 Jul; 81(13):6927-35. PubMed ID: 17409158
[TBL] [Abstract][Full Text] [Related]
42. [Effects of canine IL-2 and IL-7 genes on enhancing immunogenicity of canine parvovirus VP2 gene vaccine in mice].
Chen H; Zhong F; Li X; Wang L; Sun Y; Neng C; Zhang K; Li W; Wen J
Wei Sheng Wu Xue Bao; 2012 Nov; 52(11):1392-9. PubMed ID: 23383511
[TBL] [Abstract][Full Text] [Related]
43. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.
Söderlund M; Brown CS; Spaan WJ; Hedman L; Hedman K
J Infect Dis; 1995 Dec; 172(6):1431-6. PubMed ID: 7594699
[TBL] [Abstract][Full Text] [Related]
44. Persistent parvovirus B19 infection detected by specific CD4+ T-cell responses in a patient with hepatitis and polyarthritis.
Pongratz G; Lindner J; Modrow S; Schimanski S; Schölmerich J; Fleck M
J Intern Med; 2009 Sep; 266(3):296-301. PubMed ID: 19549095
[TBL] [Abstract][Full Text] [Related]
45. Up-regulation of adhesion molecule expression and induction of TNF-alpha on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein.
Tzang BS; Tsai CC; Chiu CC; Shi JY; Hsu TC
Clin Chim Acta; 2008 Sep; 395(1-2):77-83. PubMed ID: 18538665
[TBL] [Abstract][Full Text] [Related]
46. Human parvovirus B19 VP2 empty capsids bind to human villous trophoblast cells in vitro via the globoside receptor.
Wegner CC; Jordan JA
Infect Dis Obstet Gynecol; 2004 Jun; 12(2):69-78. PubMed ID: 15739820
[TBL] [Abstract][Full Text] [Related]
47. Report of a collaborative study to calibrate the Second International Standard for parvovirus B19 antibody.
Ferguson M; Heath A
Biologicals; 2004 Dec; 32(4):207-12. PubMed ID: 15572102
[TBL] [Abstract][Full Text] [Related]
48. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
[TBL] [Abstract][Full Text] [Related]
49. Comparison of immune responses induced by porcine parvovirus virus-like particles and inactivated vaccine.
Tian W; Qiu Z; Cui Y; Zhang J; Ma X; Cui S; Zheng S
Pak J Pharm Sci; 2019 Jan; 32(1(Special)):377-382. PubMed ID: 30852473
[TBL] [Abstract][Full Text] [Related]
50. Lymphoproliferative responses after infection with human parvovirus B19.
von Poblotzki A; Gerdes C; Reischl U; Wolf H; Modrow S
J Virol; 1996 Oct; 70(10):7327-30. PubMed ID: 8794392
[TBL] [Abstract][Full Text] [Related]
51. Expressions of Bovine IFN-gamma and foot-and-mouth disease VP1 antigen in P. pastoris and their effects on mouse immune response to FMD antigens.
Shi XJ; Wang B; Zhang C; Wang M
Vaccine; 2006 Jan; 24(1):82-9. PubMed ID: 16135391
[TBL] [Abstract][Full Text] [Related]
52. Recombinant Virus-like Particles of Human Parvovirus B19 with the Internal Location of VP1 Unique Region Produced by
Shao S; Wang Q; Jin Y; Zhang X; Liu Z; Chen S; Wu H; Yang S; Tang F; Su J; Liang Y; Zhang J; Li Q
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366508
[TBL] [Abstract][Full Text] [Related]
53. Report of a collaborative study to establish the international standard for parvovirus B19 serum IgG.
Ferguson M; Walker D; Cohen B
Biologicals; 1997 Sep; 25(3):283-8. PubMed ID: 9324996
[TBL] [Abstract][Full Text] [Related]
54. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops.
Enders M; Weidner A; Rosenthal T; Baisch C; Hedman L; Söderlund-Venermo M; Hedman K
J Infect Dis; 2008 Jan; 197(1):58-62. PubMed ID: 18171285
[TBL] [Abstract][Full Text] [Related]
55. The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability.
Dorsch S; Kaufmann B; Schaible U; Prohaska E; Wolf H; Modrow S
J Gen Virol; 2001 Jan; 82(Pt 1):191-199. PubMed ID: 11125172
[TBL] [Abstract][Full Text] [Related]
56. Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults.
Vandepapelière P; Rehermann B; Koutsoukos M; Moris P; Garçon N; Wettendorff M; Leroux-Roels G
Vaccine; 2005 Apr; 23(20):2591-601. PubMed ID: 15780441
[TBL] [Abstract][Full Text] [Related]
57. Canine parvovirus capsid assembly and differences in mammalian and insect cells.
Yuan W; Parrish CR
Virology; 2001 Jan; 279(2):546-57. PubMed ID: 11162810
[TBL] [Abstract][Full Text] [Related]
58. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
Gómez CE; Abaitua F; Rodríguez D; Esteban M
Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
[TBL] [Abstract][Full Text] [Related]
59. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
[TBL] [Abstract][Full Text] [Related]
60. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
Zhao HP; Sun JF; Li N; Sun Y; Wang Y; Qiu HJ
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):158-66. PubMed ID: 19411115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
